Completed PHASE4 INTERVENTIONAL 2-arm NCT00555282

Rate of Catheter Colonization and Risk of Bloodstream Infection During Use of Two Different Central Venous Catheters (CVC)

Rate of Catheter Colonization and Risk of Bloodstream Infection During Use of a Standard Central Venous Catheter (CVC) in Comparison to a Coated CVC

Sponsor: B. Braun Melsungen AG

Conditions Bacteriaemia Catheter Related Bloodstream Infection

Interventions central venous catheter

Updated 6 times since 2017 Last updated: Feb 4, 2010 Started: Nov 30, 2005 Primary completion: Jul 31, 2009 Completion: Jul 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Bacteriaemia and Catheter Related Bloodstream Infection and is currently completed. B. Braun Melsungen AG leads this study, which shows 6 recorded versions since 2005 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Nov 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

B. Braun Melsungen AG

Data source: B. Braun Melsungen AG

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brno, Czechia
• Prague, Czechia